Cargando…
Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study)
BACKGROUND: In the case of breast cancer (BC), radiotherapy (RT) helps reduce locoregional recurrence and BC-related deaths but can lead to cardiotoxicity, resulting in an increased risk of long-term major cardiovascular events. It is therefore of primary importance to early detect subclinical left...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275564/ https://www.ncbi.nlm.nih.gov/pubmed/35837099 http://dx.doi.org/10.3389/fonc.2022.883679 |
_version_ | 1784745513170501632 |
---|---|
author | Locquet, Médéa Spoor, Daan Crijns, Anne van der Harst, Pim Eraso, Arantxa Guedea, Ferran Fiuza, Manuela Santos, Susana Constantino Rosa Combs, Stephanie Borm, Kai Mousseaux, Elie Gencer, Umit Frija, Guy Cardis, Elisabeth Langendijk, Hans Jacob, Sophie |
author_facet | Locquet, Médéa Spoor, Daan Crijns, Anne van der Harst, Pim Eraso, Arantxa Guedea, Ferran Fiuza, Manuela Santos, Susana Constantino Rosa Combs, Stephanie Borm, Kai Mousseaux, Elie Gencer, Umit Frija, Guy Cardis, Elisabeth Langendijk, Hans Jacob, Sophie |
author_sort | Locquet, Médéa |
collection | PubMed |
description | BACKGROUND: In the case of breast cancer (BC), radiotherapy (RT) helps reduce locoregional recurrence and BC-related deaths but can lead to cardiotoxicity, resulting in an increased risk of long-term major cardiovascular events. It is therefore of primary importance to early detect subclinical left ventricular (LV) dysfunction in BC patients after RT and to determine the dose–response relationships between cardiac doses and these events. METHODS: Within the frame of the MEDIRAD European project (2017–2022), the prospective multicenter EARLY‐HEART study (ClinicalTrials.gov Identifier: NCT03297346) included chemotherapy naïve BC women aged 40–75 years and treated with lumpectomy and adjuvant RT. Myocardial strain analysis was provided using speckle‐tracking echocardiography performed at baseline and 6 months following RT. A global longitudinal strain (GLS) reduction >15% between baseline and follow-up was defined as a GLS-based subclinical LV dysfunction. Individual patient dose distributions were obtained using multi-atlas-based auto-segmentation of the heart. Dose-volume parameters were studied for the whole heart (WH) and left ventricle (LV). RESULTS: The sample included 186 BC women (57.5 ± 7.9 years, 64% left-sided BC). GLS-based subclinical LV dysfunction was observed in 22 patients (14.4%). These patients had significantly higher cardiac exposure regarding WH and LV doses compared to patients without LV dysfunction (for mean WH dose: 2.66 ± 1.75 Gy versus 1.64 ± 0.96 Gy, p = 0.01). A significantly increased risk of subclinical LV dysfunction was observed with the increase in the dose received to the WH [ORs from 1.13 (V(5)) to 1.74 (D(mean)); p <0.01] and to the LV [ORs from 1.10 (V(5)) to 1.46 (D(mean)); p <0.01]. Based on ROC analysis, the LV-V(5) parameter may be the best predictor of the short-term onset of subclinical LV dysfunction. CONCLUSION: These results highlighted that all cardiac doses were strongly associated with the occurrence of subclinical LV dysfunction arising 6 months after BC RT. Whether measurements of GLS at baseline and 6 months after RT combined with cardiac doses can early predict efficiently subclinical events occurring 24 months after RT remains to be investigated. |
format | Online Article Text |
id | pubmed-9275564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92755642022-07-13 Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) Locquet, Médéa Spoor, Daan Crijns, Anne van der Harst, Pim Eraso, Arantxa Guedea, Ferran Fiuza, Manuela Santos, Susana Constantino Rosa Combs, Stephanie Borm, Kai Mousseaux, Elie Gencer, Umit Frija, Guy Cardis, Elisabeth Langendijk, Hans Jacob, Sophie Front Oncol Oncology BACKGROUND: In the case of breast cancer (BC), radiotherapy (RT) helps reduce locoregional recurrence and BC-related deaths but can lead to cardiotoxicity, resulting in an increased risk of long-term major cardiovascular events. It is therefore of primary importance to early detect subclinical left ventricular (LV) dysfunction in BC patients after RT and to determine the dose–response relationships between cardiac doses and these events. METHODS: Within the frame of the MEDIRAD European project (2017–2022), the prospective multicenter EARLY‐HEART study (ClinicalTrials.gov Identifier: NCT03297346) included chemotherapy naïve BC women aged 40–75 years and treated with lumpectomy and adjuvant RT. Myocardial strain analysis was provided using speckle‐tracking echocardiography performed at baseline and 6 months following RT. A global longitudinal strain (GLS) reduction >15% between baseline and follow-up was defined as a GLS-based subclinical LV dysfunction. Individual patient dose distributions were obtained using multi-atlas-based auto-segmentation of the heart. Dose-volume parameters were studied for the whole heart (WH) and left ventricle (LV). RESULTS: The sample included 186 BC women (57.5 ± 7.9 years, 64% left-sided BC). GLS-based subclinical LV dysfunction was observed in 22 patients (14.4%). These patients had significantly higher cardiac exposure regarding WH and LV doses compared to patients without LV dysfunction (for mean WH dose: 2.66 ± 1.75 Gy versus 1.64 ± 0.96 Gy, p = 0.01). A significantly increased risk of subclinical LV dysfunction was observed with the increase in the dose received to the WH [ORs from 1.13 (V(5)) to 1.74 (D(mean)); p <0.01] and to the LV [ORs from 1.10 (V(5)) to 1.46 (D(mean)); p <0.01]. Based on ROC analysis, the LV-V(5) parameter may be the best predictor of the short-term onset of subclinical LV dysfunction. CONCLUSION: These results highlighted that all cardiac doses were strongly associated with the occurrence of subclinical LV dysfunction arising 6 months after BC RT. Whether measurements of GLS at baseline and 6 months after RT combined with cardiac doses can early predict efficiently subclinical events occurring 24 months after RT remains to be investigated. Frontiers Media S.A. 2022-06-28 /pmc/articles/PMC9275564/ /pubmed/35837099 http://dx.doi.org/10.3389/fonc.2022.883679 Text en Copyright © 2022 Locquet, Spoor, Crijns, van der Harst, Eraso, Guedea, Fiuza, Santos, Combs, Borm, Mousseaux, Gencer, Frija, Cardis, Langendijk and Jacob https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Locquet, Médéa Spoor, Daan Crijns, Anne van der Harst, Pim Eraso, Arantxa Guedea, Ferran Fiuza, Manuela Santos, Susana Constantino Rosa Combs, Stephanie Borm, Kai Mousseaux, Elie Gencer, Umit Frija, Guy Cardis, Elisabeth Langendijk, Hans Jacob, Sophie Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) |
title | Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) |
title_full | Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) |
title_fullStr | Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) |
title_full_unstemmed | Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) |
title_short | Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) |
title_sort | subclinical left ventricular dysfunction detected by speckle-tracking echocardiography in breast cancer patients treated with radiation therapy: a six-month follow-up analysis (medirad early‐heart study) |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275564/ https://www.ncbi.nlm.nih.gov/pubmed/35837099 http://dx.doi.org/10.3389/fonc.2022.883679 |
work_keys_str_mv | AT locquetmedea subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT spoordaan subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT crijnsanne subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT vanderharstpim subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT erasoarantxa subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT guedeaferran subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT fiuzamanuela subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT santossusanaconstantinorosa subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT combsstephanie subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT bormkai subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT mousseauxelie subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT gencerumit subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT frijaguy subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT cardiselisabeth subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT langendijkhans subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy AT jacobsophie subclinicalleftventriculardysfunctiondetectedbyspeckletrackingechocardiographyinbreastcancerpatientstreatedwithradiationtherapyasixmonthfollowupanalysismediradearlyheartstudy |